0001179110-19-011948.txt : 20191120
0001179110-19-011948.hdr.sgml : 20191120
20191120202317
ACCESSION NUMBER: 0001179110-19-011948
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191118
FILED AS OF DATE: 20191120
DATE AS OF CHANGE: 20191120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schorno Dean L
CENTRAL INDEX KEY: 0001509688
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29889
FILM NUMBER: 191235480
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RIGEL PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001034842
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943248524
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1180 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
MAIL ADDRESS:
STREET 1: 1180 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
edgar.xml
FORM 4 -
X0306
4
2019-11-18
0
0001034842
RIGEL PHARMACEUTICALS INC
RIGL
0001509688
Schorno Dean L
RIGEL PHARMACEUTICALS, INC.
1180 VETERANS BLVD.
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
EVP &Chief Financial Officer
Employee Stock Option (right to buy)
3.44
2019-11-18
4
A
0
83750
0
A
2028-06-04
Common Stock
83750
83750
D
The reporting person was granted a performance based option to purchase 83,750 shares of common stock on June 4, 2018. Thus,the exercise price of this option is $3.44 (the closing price of the issuer's common stock on Nasdaq the day of the grant). In light of the performance-based vesting condition of this grant, this grant was not reportable under Section 16 until the performance metric was satisfied. On November 18, 2019, it was determined that the performance metric had been met.
/s/Dolly Vance (Attorney-in-Fact)
2019-11-20